Title : Pioglitazone inhibits advanced glycation end product-induced matrix metalloproteinases and apoptosis by suppressing the activation of MAPK and NF-κB.

Pub. Date : 2016 Oct

PMID : 27515513






3 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Pioglitazone inhibits advanced glycation end product-induced matrix metalloproteinases and apoptosis by suppressing the activation of MAPK and NF-kappaB. Pioglitazone nuclear factor kappa B subunit 1 Homo sapiens
2 AGEs-induced degradation of IkappaBalpha and translocation of nuclear NF-kappaB p65 is reversed by pioglitazone. Pioglitazone nuclear factor kappa B subunit 1 Homo sapiens
3 These findings suggest that pioglitazone, a PPARgamma agonist, inhibits AGEs-induced chondrocytes apoptosis and degeneration via suppressing the activation of MAPK and NF-kappaB. Pioglitazone nuclear factor kappa B subunit 1 Homo sapiens